Ted Davis of Kilpatrick Townsend & Stockton LLP will join us on March 12 for a discussion on recent developments in trademark and unfair competition law.

Mr. Davis’s presentation will cover the invalidation of the prohibition in Section 2(a) of the Lanham Act on the registration of potentially disparaging marks, the differences among regional circuits on accounting of defendants’ profits, the continued influence of the Supreme Court’s Octane Fitness decision, and ongoing findings of fraud on the USPTO by the courts.

To learn more and register, click here.

Patrick McManamny of FB Rice will join us on April 11 for a discussion on rstrategies for securing patent rights in Australia and neighboring countries.

Mr. McManamny’s remarks will include information on how to rapidly obtain grant of enforceable rights that are likely to stand up to a challenge, as well as options for challenging or preventing grant of competitors’ patents.

To learn more and register, click here.

Nic Brentlinger of Dinsmore will discuss the surprising, unanimous Supreme Court decision of Helsinn v. Teva.

Mr. Brentlinger’s remarks will include an explanation of nuances of the phrase “or otherwise available to the public” under Section 102(a)(1) in light of the Supreme Court’s ruling and will give practice tips for how to safeguard technology to ensure protection against inadvertent disclosures.

To learn more and register, click here.

Kevin Flynn of BakerHostetler will discuss IP-based import investigations at the U.S. International Trade Commission (ITC). 

Mr. Flynn’s remarks will include an overview of the ITC and Section 337, the progression of Section 337 investigations, strategies from both the IP-holder’s and accused infringer’s perspective, and the reasons for litigating at the ITC rather than in district court..

To learn more and register, click here.

John Luken, April Besl, and Oleg Khariton of Dinsmore & Shohl will provide an update on Supreme Court and Federal Circuit intellectual property decisions of significance in 2018 and 2019. 

The speakers will cover Helsinn v. Teva (AIA On Sale Bar), WesternGeco LLC v. ION Geophysical Corp. (recovering overseas damages for Section 271(f) violation), Texas Advanced Optoelectronic Solutions Inc. v. Renesas Electronics America Inc. (when an offer to sell takes place), and Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc. (101 eligibility and method of treatment claims)..

To learn more and register, click here.